We have an innovative approach to capturing EMR data for use in all commercial life science settings. Our data is truly global with specific targeting of small cohorts and rare diseases.
Designated Rare Diseases are hard to capture but Tudor Health achieves this through highly targeted data capture. Also, targeted institutions are often required as rare disease treatment is often concentrated.
Many diseases have sub-cohorts with very specific characteristics – genotype is increasingly common. Tudor Health uses over-sampling methods to ensure the capture of sufficient data in each niche cohort.
Each oncology sector comprises many sub-cohorts, each of which can be targeted by the Tudor Health methodology. Over-sampling and targeted institution data capture form core elements for this complex area.
Tudor Health reaches higher numbers of patients in targeted patient populations because of our new, patient-centric platform to capture EMR data. Instead of boiling the ocean, we can directly access the target patients. This allows us to capture the long tail of hyper-targeted patient populations better than anybody.
The Tudor Health platform connects to thousands of HCPs around the world and has established frictionless capturing technology across a wide range of EMR systems.
Our approach to capturing data differs from other sources in these key respects:
Our data capture is NOT drawn directly from EMR software. This allows us to capture data from institutions with any EMR technology. We establish a strong relationship with individual HCPs to capture data, not a technology link.
Our longitudinal data are captured by updating data on the same set of patients. This gives us the opportunity to gradually expand the extent of the data held on each patient, which gives us greater depth of analytical options.
Our data capture is NOT drawn directly from EMR software. This allows us to capture data from institutions with any EMR technology. We establish a strong relationship with individual HCPs to capture data, not a technology link.
Our longitudinal data are captured by updating data on the same set of patients. This gives us the opportunity to gradually expand the extent of the data held on each patient, which gives us greater depth of analytical options.
We use complex sampling techniques to ensure that we have sufficient data on rare cohorts to give analytical reliability. By over-sampling rare cohorts we provide insights at a level that other sources find difficult.
The Tudor Health data model uses an identical data-capture method in all countries. This makes the data consistent within country and comparable across countries. The data is uniquely usable for all purposes.
We use complex sampling techniques to ensure that we have sufficient data on rare cohorts to give analytical reliability. By over-sampling rare cohorts we provide insights at a level that other sources find difficult.
The Tudor Health data model uses an identical data-capture method in all countries. This makes the data consistent within country and comparable across countries.
The combination of these differences makes the Tudor Health data richer than many other sources. The methods lead to the following benefits:
Improved coverage of patients from all types of institutions, including specific target institutions if required.
Coverage of patients in all countries and across all specialties, including rare and very uncommon genetic conditions.
The ability to have a data use agreement that is much broader and only not limited to research purposes.
Understanding Health Equity Let’s explore the significance of health equity and why it has become…
Tudor Health is delighted to announce that data scientist John Elhagar has joined our growing…
Government Control The organisation and management of the health care system is different in each…
Our data is sourced from all countries and specifically targets small cohorts and rare diseases, making it perfect for commercial use.
Tudor Health Inc, 1100 H St NW, Suite E-101, Washington DC 20005, USA
Simply enter your name and email below to receive occasional emails with news and industry insight.*
*Your information will only be used to send our newsletter. It wont be sold or passed to any third party. Obviously, you can unsubscribe at any time!